Petros Grivas, MD, PhD

/content/dam/www/faculty-photos/G/petros-grivas/petros-grivas.jpg
Dr. Petros Grivas MD, PhD
FACULTY MEMBER

Petros Grivas, MD, PhD

Professor, Clinical Research Division, Fred Hutch

Professor
Clinical Research Division, Fred Hutch

Fax: 206.606.1943
Mail Stop: LG-465

Dr. Petros Grivas is an oncologist with expertise in treating genitourinary cancers such as bladder cancer, prostate cancer and testicular cancer. His clinical research helped lead to FDA approval of new drugs to treat the most common type of bladder cancer. Dr. Grivas currently leads clinical trials that investigate the use of checkpoint inhibitors. These immunotherapy drugs release the brakes on a patient’s immune system and help it mount a better response to cancer. 

Other Appointments & Affiliations

Clinical Director, Genitourinary Cancers Program, University of Washington Medicine

Clinical Director
Genitourinary Cancers Program, University of Washington Medicine

Professor, Department of Medicine, Division of Oncology, University of Washington School of Medicine

Professor, Department of Medicine
Division of Oncology, University of Washington School of Medicine

Education

Fellowship, Hematology/Oncology, University of Michigan

Residency, Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA

PhD, Medical Oncology, University of Patras School of Medicine, Greece

MD, University of Patras School of Medicine, Greece